Genprex is a clinical stage gene therapy company developing a new approach to treating cancer, based upon their novel proprietary technology platform, including their initial product candidate, Oncoprex immunogene therapy, or Oncoprex.
$5.00 - $5.00
To view the prospectus for IPO, or any offering listed on ClickIPO,
download the ClickIPO app...
or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277